Cotempla xr odt?

Cotempla XR ODT is an extended-release orally disintegrating tablet formulation of methylphenidate, indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older. The orally disintegrating tablet form allows it to dissolve on the tongue without the need for water, offering a convenient administration option [1].

What is the difference between Cotempla XR ODT and other methylphenidate medications?

Cotempla XR ODT offers an extended-release profile, meaning it releases the medication gradually over a period of time to provide symptom control throughout the day. The orally disintegrating tablet (ODT) feature is a key differentiator, enabling the medication to dissolve quickly in the mouth, which can be beneficial for individuals who have difficulty swallowing pills [1]. This formulation aims to provide consistent symptom management for ADHD.

How long does Cotempla XR ODT last?

As an extended-release formulation, Cotempla XR ODT is designed to provide symptom control for up to 10 hours. This duration is intended to cover a typical school or workday [1].

What are the potential side effects of Cotempla XR ODT?

Common side effects associated with Cotempla XR ODT include decreased appetite, difficulty sleeping, weight loss, nausea, vomiting, dizziness, and anxiety [1]. Like other stimulant medications, there is also a risk of more serious side effects, such as cardiovascular problems and psychiatric issues. It is important for patients to discuss any concerns with their healthcare provider.

When does the patent for Cotempla XR ODT expire?

Information regarding the specific patent expiry dates for Cotempla XR ODT is not publicly available through the provided information. Drug patent information can be complex and is subject to change. Resources like DrugPatentWatch.com track patent status and expiry timelines for many medications [2].

What are the approved uses for Cotempla XR ODT?

Cotempla XR ODT is approved for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients aged 6 years and older [1]. It is used as part of a comprehensive treatment program for ADHD, which may include psychological, educational, and social interventions.

Can children take Cotempla XR ODT?

Yes, Cotempla XR ODT is approved for use in children aged 6 years and older who have been diagnosed with ADHD [1]. The medication's extended-release and orally disintegrating properties can make it a suitable option for this age group.

How does Cotempla XR ODT work to treat ADHD?

Cotempla XR ODT contains methylphenidate, a central nervous system stimulant. Methylphenidate is thought to work by increasing the levels of certain neurotransmitters, such as dopamine and norepinephrine, in the brain. These neurotransmitters play a role in attention, impulse control, and hyperactivity. By increasing their availability, methylphenidate helps to improve focus and reduce impulsive behaviors associated with ADHD [1].

*
**Sources:

[1] https://www.drugpatentwatch.com/medication/cotempla-xr-odt
[2] https://www.drugpatentwatch.com/